[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554584":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":62,"collaborators":64,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":75,"sex":81,"minAge":82,"maxAge":18,"enrollmentInfo":83,"targetDuration":18,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Corrie Virtual Atrial Fibrillation Management Program","EXPERIMENTAL","Multicomponent virtual atrial fibrillation management program",[13],"Combination Product: Corrie Virtual Atrial Fibrillation Management Program",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","NO_INTERVENTION","Receives usual care. Usual care is defined as care according to the patients care team's standard practice",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"COMBINATION_PRODUCT","Intervention aims to implement a comprehensive digital atrial fibrilation guideline-recommended toolkit",[9],[25],{"name":26,"affiliation":5,"role":27},"Nino Isakadze, MD","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Nino Isakadze","CONTACT","410-955-5999","nisakad1@jhmi.edu",[35,54],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Johns Hopkins Bayview Medical Center","RECRUITING","Baltimore","Maryland","21224","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-76.61219,39.29038,{"lat":47,"lon":46},[50],{"name":51,"role":31,"phone":52,"phoneExt":18,"email":53},"Natalie Horstman","443-839-0803","nhorstm3@jh.edu",{"facility":55,"status":37,"city":38,"state":39,"zip":56,"country":41,"countryCode":42,"cosmosGeoPoint":57,"geoPoint":59,"contacts":60},"Johns Hopkins Outpatient Center","21287",{"type":44,"coordinates":58},[46,47],{"lat":47,"lon":46},[61],{"name":51,"role":31,"phone":52,"phoneExt":18,"email":53},{"type":63,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[65,68,71],{"name":66,"class":67},"Pharmaceutical Research & Manufacturers Of America Foundation","UNKNOWN",{"name":69,"class":70},"Apple Inc.","INDUSTRY",{"name":72,"class":70},"Itamar-Medical, Israel","100554584","mobile-health-technology-enabled-afib-management-100554584",false,"NCT06500988","Mobile Health Technology-Enabled AFib Management","Patient Centered Mobile Health Technology-Enabled Atrial Fibrillation Management: Phase 2","mTECH Afib","Inclusion Criteria:\n\n1. Aged 18 or older at time of consent\n2. Diagnosis of paroxysmal (Afib lasting less than 7 days) or persistent (7 days or longer) atrial fibrillation\n3. BMI (Body Mass Index) ≥ 27.0\n\nExclusion Criteria:\n\n1. Permanent Afib (decision has been made not to attempt sinus rhythm)\n2. Severe valvular disease\n3. Moderate mitral valve stenosis\n4. Prior cardiac surgery\n5. Presence of implanted cardiac device\n6. History of cardiac arrest\n7. Left ventricular ejection fraction (LVEF) ≤ 35%\n8. Life expectancy \\\u003C 1 year\n9. Non-English speaking\n10. Treating clinician deems unsafe for exercise\n11. Any other reason that makes patient unsuitable for study at the discretion of the PI","ALL","18 Years",{"count":84,"type":85},248,"ESTIMATED","INTERVENTIONAL",[88],"NA","The overall objective of this proposal is to evaluate the effect on quality of life of a comprehensive digital atrial fibrillation (AFib) management tool that will empower patients to a) take an active role in learning about AFib management options, starting and adhering to evidence-based therapies and lifestyle changes and b) to guide the patients during AFib episodes which are associated with anxiety and impairment in quality of life.\n\nResearchers plan to evaluate the effectiveness of this novel digital toolkit in improving quality of life and decreasing AFib burden in a randomized clinical trial (RCT). A pilot study assessing feasibility and retention of the intervention was previously conducted (NCT05400837)",[91,92],"Atrial Fibrillation","Behavior",[94,91,95,96,97],"Remote Patient Monitoring","Risk Factor Modification","Digital Health","Mobile Health","2026-04-15",{"date":100,"type":101},"2026-04-20","ACTUAL",{"date":103,"type":101},"2025-06-03",{"date":105,"type":85},"2028-06",{"name":5,"class":6},2]